Bulletin of the Korean Chemical Society

Korean Chemical Society (대한화학회)
권호 표지
DOI QR코드

DOI QR Code

Hsp27 Reduces Phosphorylated Tau and Prevents Cell Death in the Human Neuroblastoma Cell Line SH-SY5Y

  • Ahn, Junseong (Department of Chemistry, College of Natural Science, Seoul National University) ;
  • Kim, Hyeseon (Department of Chemistry, College of Natural Science, Seoul National University) ;
  • Park, Jong-Sang (Department of Chemistry, College of Natural Science, Seoul National University)
  • Received : 2013.01.02
  • Accepted : 2013.02.26
  • Published : 2013.05.20
Download PDF
⟨ Previous Next ⟩

Abstract

The two major symptoms characterizing Alzheimer's disease are the formation of amyloid-${\beta}$ extracellular deposits in the form of senile plaques and intracellular neurofibrillary tangles (NFTs) that consist of pathological hyperphosphorylated tau protein aggregated into insoluble paired helical filaments (PHFs). Neurons of the central nervous system have appreciable amounts of tau protein, a microtubule-associated protein. To maintain an optimal operation of nerves, the microtubules are stabilized, which is necessary to support cell structure and cellular processes. When the modified tau protein becomes dysfunctional, the cells containing misfolded tau cannot maintain cell structure. One of the pathological hallmarks of Alzheimer's disease is hyperphosphorylated tau protein. This paper shows that the small heat shock protein from humans (Hsp27) reduces hyperphosphorylated tau and prevents hyperphosphorylated tau-induced cell death of the human neuroblastoma cell line SH-SY5Y.

Keywords

References

  1. Tiraboschi, P.; Hansen, L. A.; Thal, L. J.; Corey-Bloom, J. Neurology 2004, 62, 1984-1989. https://doi.org/10.1212/01.WNL.0000129697.01779.0A
  2. Ghiso, J.; Frangione, B. Adv. Drug Deliv. Rev. 2002, 54, 1539- 1551. https://doi.org/10.1016/S0169-409X(02)00149-7
  3. Weingarten, M. D.; Lockwood, A. H.; Hwo, S. Y.; Kirschner, M. W. Proc. Natl. Acad Sci. USA. 1975, 72, 1858-1862. https://doi.org/10.1073/pnas.72.5.1858
  4. Avila, J.; Lucas, J. J.; Perez, M.; Hernandez, F. Physiol. Rev. 2004, 84, 361-384. https://doi.org/10.1152/physrev.00024.2003
  5. Augustinack, J. C.; Schneider, A.; Mandelkow, E. M., Hyman, B. T. Acta Neuropathol. 2002, 103(1), 26-35. https://doi.org/10.1007/s004010100423
  6. Billingsley, M. L.; Kincaid, R. L. Biochem. J. 1997, 323, 577-591.
  7. Johnson, G. V.; Jenkins, S. M. J. Alzheimers Dis. 1999, 1(4-5), 307-328.
  8. Liu, F.; Grundke-Iqbal, I.; Iqbal, K.; Gong, C. X. Eur. J. Neurosci. 2005, 22(8), 1942-1950. https://doi.org/10.1111/j.1460-9568.2005.04391.x
  9. Zhang, Z.; Simpkins, J. W. Brain Res. 2010, 1345, 176-181. https://doi.org/10.1016/j.brainres.2010.04.074
  10. Shimura, H.; Miura-Shimura, Y.; Kosik, K. S. J. Biol. Chem. 2004, 279, 17957-17962. https://doi.org/10.1074/jbc.M400351200
  11. Kosik, K. S.; Shimura, H. Biochim. Biophys. Acta 2005, 1739, 298-310. https://doi.org/10.1016/j.bbadis.2004.10.011

Cited by

  1. Protective Effect of Tat PTD-Hsp27 Fusion Protein on Tau Hyperphosphorylation Induced by Okadaic Acid in the Human Neuroblastoma Cell Line SH-SY5Y vol.35, pp.7, 2015, https://doi.org/10.1007/s10571-015-0199-1